Dr. Ruckle is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Connect with other colleagues in the same hospital or clinic
- Search all U.S. specialist profiles and refer a patient
- Read the latest clinical news and earn CME/CEU credits
Office
1402 S Brookside Ter
Tacoma, WA 98465Phone+1 253-448-8690- Is this information wrong?
Education & Training
- Mayo Clinic College of Medicine and Science (Rochester)Residency, Internal Medicine, 1982 - 1984
- Mayo Clinic College of Medicine and Science (Rochester)Residency, Internal Medicine, 1981 - 1981
- Loma Linda University Health Education ConsortiumResidency, Internal Medicine, 1981 - 1981
- Loma Linda University School of MedicineClass of 1980
Certifications & Licensure
- CA State Medical License 1986 - Present
- HI State Medical License 2000 - 2026
- WA State Medical License 1987 - 2025
- NC State Medical License 1984 - 1988
- MN State Medical License 1982 - 1987
- American Board of Internal Medicine Internal Medicine
Publications & Presentations
PubMed
- 11 citationsFirst-in-human randomized clinical trials of the safety and efficacy of tanezumab for treatment of chronic knee osteoarthritis pain or acute bunionectomy pain.Patricia Ann Walicke, Franz F. Hefti, Roxanne Bales, Shiao-Ping Lu, Jon L Ruckle, Mark T. Brown, Christine R. West, David L. Shelton> ;Pain Reports. 2018 May 9
- 5 citationsPharmacokinetics and Pharmacodynamics of Anacetrapib Following Single Doses in Healthy, Young Japanese and White Male SubjectsRajesh Krishna, Ferdous Gheyas, Yang Liu, Josee Cote, Omar F Laterza, Jon L. Ruckle, John A. Wagner, Andrew Denker> ;Journal of Clinical Pharmacology. 2018 Feb 1
- 26 citationsPhase-0/microdosing studies using PET, AMS, and LC-MS/MS: a range of study methodologies and conduct considerations. Accelerating development of novel pharmaceuticals ...Tal Burt, Christy S. John, Jon L Ruckle, Le T. Vuong> ;Expert Opinion on Drug Delivery. 2017 May 1
- Join now to see all
Press Mentions
- Cardax Launches Human Clinical Trial Targeting Cardiovascular Inflammatory HealthOctober 2nd, 2018
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: